...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Antipruritic Effect of Ethyl Acetate Extract from Fructus cnidii in Mice with 2,4-Dinitrofluorobenzene-Induced Atopic Dermatitis
【24h】

Antipruritic Effect of Ethyl Acetate Extract from Fructus cnidii in Mice with 2,4-Dinitrofluorobenzene-Induced Atopic Dermatitis

机译:2,4-二硝基氟苯诱导的特应性皮炎小鼠乙酸乙酯提取物乙酸乙酯提取物的抗腐蚀作用

获取原文
           

摘要

Atopic dermatitis (AD) is a common inflammatory skin disease characterized by intense pruritus and skin lesions. The exact cause of AD is not yet known and the available therapeutic strategies for AD are limited. Fructus cnidii is commonly used in traditional Chinese medicine as an herb for treating chronic itch. However, the mechanism underlying the antipruritic effects of Fructus cnidii is not well understood. In the present study, we investigated the antipruritic effect of locally administered ethyl acetate extract from Fructus cnidii (EAEFC) to 2,4-dinitrofluorobenzene- (DNFB-) induced AD in a mouse model. The scratching behavior, skin thickness, dermatitis score, weight, blood immunoglobulin E (IgE) level, and itch-related cytokine levels were subsequently monitored and evaluated. Results showed that EAEFC treatment attenuated the DNFB-induced AD-like symptoms by alleviating the skin lesions and decreasing the dermatitis score. Hematoxylin and eosin (H&E) and toluidine blue (TB) staining analyses demonstrated that EAEFC mitigated the DNFB-induced increase in skin thickness and prevented the infiltration of mast cells. Behavioral tests showed that EAEFC decreased the DNFB-induced acute and chronic scratching behaviors. Furthermore, EAEFC reduced the levels of itch-related cytokines, such as thymic stromal lymphopoietin (TSLP), interleukin- (IL-) 17, IL-33, and IL-31, and the DNFB-induced boost in serum IgE. Collectively, these results suggest that EAEFC is a potential therapeutic candidate for the treatment of chronic itch in AD.
机译:特应性皮炎(AD)是一种常见的炎症性皮肤病,其特征在于强烈的瘙痒和皮肤病变。广告的确切原因尚不清楚,广告的可用治疗策略是有限的。 CNIDII常用于中药作为一种治疗慢性瘙痒的草药。然而,CNIDII的抗腐蚀效应的潜在机制尚不清楚。在本研究中,我们研究了小鼠模型中局部施用的乙酰乙酸乙酯提取物的氨基乙酸乙酯提取物至2,4-二硝基氟苯 - (DNFB-)诱导的AD。随后监测和评估刮擦行为,皮肤厚度,皮炎评分,重量,血液免疫球蛋白E(IgE)水平和瘙痒相关的细胞因子水平。结果表明,EAEFC治疗通过减轻皮肤病变并降低皮炎得分来减弱DNFB诱导的症状。血杂志和曙红(H&E)和甲苯胺蓝(TB)染色分析表明,EAEFC减轻了DNFB诱导的皮肤厚度的增加,并阻止了肥大细胞的渗透。行为测试表明,EAEFC降低了DNFB诱导的急性和慢性划伤行为。此外,EAEFC降低了瘙痒相关细胞因子的水平,例如胸腺基质淋巴喹啉素(TSLP),白细胞介素 - (IL-)17,IL-33和IL-31,以及DNFB诱导的血清IgE升压。总的来说,这些结果表明EAEFC是治疗AD中慢性瘙痒的潜在治疗候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号